Back
Viking Therapeutics Stock Price Chart
Sponsored
VKTX
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
80
VKTX
Viking Therapeutics
Last Price:
68.17
Seasonality Move:
18.2%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.79 | Buy |
20-day SMA: | 61.45 | Buy |
50-day SMA: | 58.5 | Buy |
200-day SMA: | 52.22 | Buy |
8-day EMA: | 62.78 | Buy |
20-day EMA: | 61.14 | Buy |
50-day EMA: | 59.58 | Buy |
200-day EMA: | 51.11 | Buy |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.38 | Buy |
Relative Strength Index (14 RSI): | 56.7 | Buy |
Chaikin Money Flow: | 155400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.21 - 65.49) | Buy |
Bollinger Bands (100): | (51.86 - 68.76) | Buy |
Viking Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 64.46 while VKTX 8-day simple moving average is 61.79, which is a Buy signal.
- The stock price of VKTX is 64.46 while Viking Therapeutics 20-day SMA is 61.45, which makes it a Buy.
- Viking Therapeutics 50-day simple moving average is 58.50 while VKTX share price is 64.46, making it a Buy technically.
- VKTX stock price is 64.46 and Viking Therapeutics 200-day simple moving average is 52.22, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Buy
80
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Buy
The current Viking Therapeutics [VKTX] share price is $64.46. The Score for VKTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
Viking Therapeutics Stock Info
Market Cap:
7.14B
Price in USD:
64.46
Share Volume:
2.13M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
8.28
Buy
80
Viking Therapeutics (VKTX)
is a Buy
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 64.46 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is not overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 64.46 while VKTX 8-day exponential moving average is 62.78, which is a Buy signal.
- The stock price of VKTX is 64.46 while Viking Therapeutics 20-day EMA is 61.14, which makes it a Buy.
- Viking Therapeutics 50-day exponential moving average is 59.58 while VKTX share price is 64.46, making it a Buy technically.
- VKTX stock price is 64.46 and Viking Therapeutics 200-day simple moving average is 51.11, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is 1.38, suggesting Viking Therapeutics is a Buy
- Viking Therapeutics Relative Strength Index (RSI) is 56.7, which suggest Viking Therapeutics is overbought
- The Bollinger Bands (25) for Viking Therapeutics is (57.21 - 65.49), which suggest Viking Therapeutics is a Buy
- The Bollinger Bands (100) for Viking Therapeutics is (51.86 - 68.76), which suggest Viking Therapeutics is a Buy
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.